Palmetto Partners, Ltd. - Net Worth and Insider Trading
Palmetto Partners, Ltd. Net Worth
The estimated net worth of Palmetto Partners, Ltd. is at least $7 Million dollars as of 2024-11-13. Palmetto Partners, Ltd. is the 10% Owner of Xeris Biopharma Holdings Inc and owns about 2,110,061 shares of Xeris Biopharma Holdings Inc (XERS) stock worth over $7 Million. Details can be seen in Palmetto Partners, Ltd.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Palmetto Partners, Ltd. has not made any transactions after 2018-06-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Palmetto Partners, Ltd.
Palmetto Partners, Ltd. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Palmetto Partners, Ltd. owns 1 companies in total, including Xeris Biopharma Holdings Inc (XERS) .
Click here to see the complete history of Palmetto Partners, Ltd.’s form 4 insider trades.
Insider Ownership Summary of Palmetto Partners, Ltd.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XERS | Xeris Biopharma Holdings Inc | 2018-06-25 | 10 percent owner |
Palmetto Partners, Ltd. Latest Holdings Summary
Palmetto Partners, Ltd. currently owns a total of 1 stock. Palmetto Partners, Ltd. owns 2,110,061 shares of Xeris Biopharma Holdings Inc (XERS) as of June 25, 2018, with a value of $7 Million.
Latest Holdings of Palmetto Partners, Ltd.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings Inc | 2018-06-25 | 2,110,061 | 3.16 | 6,657,242 |
Holding Weightings of Palmetto Partners, Ltd.
Palmetto Partners, Ltd. Form 4 Trading Tracker
According to the SEC Form 4 filings, Palmetto Partners, Ltd. has made a total of 0 transactions in Xeris Biopharma Holdings Inc (XERS) over the past 5 years. The most-recent trade in Xeris Biopharma Holdings Inc is the acquisition of 150,000 shares on June 25, 2018, which cost Palmetto Partners, Ltd. around $2 Million.
Insider Trading History of Palmetto Partners, Ltd.
- 1
Palmetto Partners, Ltd. Trading Performance
GuruFocus tracks the stock performance after each of Palmetto Partners, Ltd.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Palmetto Partners, Ltd. is 3.77%. GuruFocus also compares Palmetto Partners, Ltd.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Palmetto Partners, Ltd. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Palmetto Partners, Ltd.'s insider trading performs compared to the benchmark.
Performance of Palmetto Partners, Ltd.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.07 | | | | | |
| Relative Return to S&P 500(%) | 2.32 | | | | | |
Palmetto Partners, Ltd. Ownership Network
Ownership Network List of Palmetto Partners, Ltd.
Ownership Network Relation of Palmetto Partners, Ltd.
Palmetto Partners, Ltd. Owned Company Details
What does Xeris Biopharma Holdings Inc do?
Who are the key executives at Xeris Biopharma Holdings Inc?
Palmetto Partners, Ltd. is the 10 percent owner of Xeris Biopharma Holdings Inc. Other key executives at Xeris Biopharma Holdings Inc include Chief Financial Officer Steven Pieper , See Remarks Shannon John Patrick Jr , and director & See Remarks Paul R Edick .
Xeris Biopharma Holdings Inc (XERS) Insider Trades Summary
Over the past 18 months, Palmetto Partners, Ltd. made no insider transaction in Xeris Biopharma Holdings Inc (XERS). Other recent insider transactions involving Xeris Biopharma Holdings Inc (XERS) include a net purchase of 25,200 shares made by John P. Schmid , a net purchase of 30,769 shares made by Shannon John Patrick Jr , and a net purchase of 28,000 shares made by Steven Pieper .
In summary, during the past 3 months, insiders sold 0 shares of Xeris Biopharma Holdings Inc (XERS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Xeris Biopharma Holdings Inc (XERS) were sold and 104,779 shares were bought by its insiders, resulting in a net purchase of 104,779 shares.
Xeris Biopharma Holdings Inc (XERS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xeris Biopharma Holdings Inc Insider Transactions
Palmetto Partners, Ltd. Mailing Address
Above is the net worth, insider trading, and ownership report for Palmetto Partners, Ltd.. You might contact Palmetto Partners, Ltd. via mailing address: 109 N. Post Oak Lane, Suite 600 Houston Tx 77024.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
